Accurate quantification of kidney function with non-sedated motion-compensated pediatric MRI

使用非镇静运动补偿小儿 MRI 准确量化肾功能

基本信息

  • 批准号:
    10230988
  • 负责人:
  • 金额:
    $ 26.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-06 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Project Summary: Ureteropelvic junction obstruction (UPJO) is an impairment of urine flow from the renal pelvis into the proximal ureter and is the most common cause of hydronephrosis in neonates. This disorder is detected in up to 7% of all maternal ultrasound scans, and an estimated 10% of these newborns have hydronephrosis, which, if left untreated, may result in early failure of functional renal development in these patients. Current methods of assessing kidney function in neonates and children are less than optimal, however. While the current reference standard, nuclear renography (MAG3), yields some useful diagnostic information; it is invasive, slow, provides low resolution, does not offer anatomic detail, and delivers potentially harmful ionizing radiation. Thus, there is an urgent, unmet need to develop a method for functional imaging of kidneys that is non-invasive, safe, accurate, reproducible and radiation-free. The primary objective of this exploratory, two-year study, therefore, is two-fold: first, to develop advanced methods of motion-compensated, high spatial and temporal resolution magnetic resonance imaging (MRI) for the improved quantification of the glomerular filtration rate (GFR), an important marker of renal function; and second, to demonstrate the superiority of this method over the current reference standard, nuclear renography (MAG3). Our application in response to PAR-18-743 is specifically aimed at developing, and evaluating motion-robust, high spatiotemporal resolution dynamic contrast-enhanced MRI (DCE-MRI) for quantifying GFR (MR-GFR) as well as creating new automated analysis software to enable the robust and reproducible assessment of differential renal function in newborns eliminating need for sedation, and in older children. Our method will overcome the technical challenges of current DCE-MRI techniques providing high temporal resolution to capture fast arterial input function dynamics required for accurate computation of GFR, compensate for unavoidable respiratory and bulk motion to reconstruct high quality images and will provide robust, fast, automated post processing techniques for accurate GFR computation. As a non-invasive, motion-robust, radiation-free imaging technique that can depict renal structures at much higher resolution, MR-GFR will offer, for the first time, a level of diagnostic information that is unattainable with MAG3. The critical importance of understanding the extent and severity of UPJO (and resulting hydronephrosis) cannot be understated; for in the absence of this information, children who stand to benefit from immediate surgery might be overlooked or delayed in receiving treatment; and those who might benefit from a more conservative approach (i.e., watching waiting) might receive an unnecessary surgical intervention. Indeed, this novel imaging approach is expected to substantially improve clinical decision-making. The successful completion of our aims will enable 1) assessment of renal function accurately; 2) predicting the likelihood of functional decline; and 3) determining whether surgery is indicated. DCE-MRI is expected to have rapid translational impact for several diseases effecting kidney function once it is introduced into clinical practice.
项目概要: 肾盂输尿管连接部梗阻(UPJO)是一种尿流从肾盂进入近端输尿管的障碍。 是新生儿肾积水的最常见原因。这种疾病在高达7%的 所有产妇的超声波扫描,估计其中10%的新生儿患有肾积水,如果留下, 未经治疗,可能导致这些患者的功能性肾发育早期衰竭。的当前方法 然而,评估新生儿和儿童的肾功能不是最佳的。虽然目前的参考 标准的核肾造影(MAG 3)可提供一些有用的诊断信息;它是侵入性的,缓慢的, 低分辨率,不能提供解剖细节,并提供潜在有害的电离辐射。因此, 迫切的、未满足的需要是开发一种用于肾的功能成像的方法,该方法是非侵入性的,安全的, 准确、可重复和无辐射。因此,这项为期两年的探索性研究的主要目标是, 是双重的:首先,发展先进的运动补偿方法,高空间和时间分辨率 磁共振成像(MRI)用于改善肾小球滤过率(GFR)的定量, 肾功能的重要标志物;第二,证明该方法优于当前方法 参考标准,核肾图(MAG 3)。我们针对PAR-18-743的申请具体如下: 旨在开发和评估运动鲁棒、高时空分辨率的动态对比度增强 MRI(DCE-MRI)用于定量GFR(MR-GFR),并创建新的自动分析软件, 对新生儿不同肾功能的可靠和可重复评估消除了镇静的需要, 以及年龄较大的儿童。我们的方法将克服当前DCE-MRI技术的技术挑战 提供高的时间分辨率以捕获精确测量所需的快速动脉输入功能动态, 计算GFR,补偿不可避免的呼吸和整体运动,以重建高质量 图像,并将提供强大的,快速的,自动后处理技术,准确的GFR计算。作为 一种无创、运动稳健、无辐射的成像技术,可以在更高的温度下描绘肾脏结构, 随着分辨率的提高,MR-GFR将首次提供MAG 3无法达到的诊断信息水平。 了解UPJO的范围和严重程度(以及由此导致的肾积水)的至关重要性 不能低估;因为在没有这些信息的情况下,儿童谁站在受益于立即 手术可能会被忽视或延迟接受治疗;那些可能受益于更多 保守方法(即,观察等待)可能接受不必要的外科手术干预。这确 新的成像方法有望大大改善临床决策。成功 完成我们的目标将能够:1)准确评估肾功能; 2)预测 功能衰退; 3)确定是否需要手术。DCE-MRI有望快速 一旦将其引入临床实践,对影响肾功能的几种疾病的转化影响。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Improving Automatic Renal Segmentation in Clinically Normal and Abnormal Paediatric DCE-MRI via Contrast Maximisation and Convolutional Networks for Computing Markers of Kidney Function.
通过对比度最大化和卷积网络计算肾功能标记物,改进临床正常和异常儿科 DCE-MRI 的自动肾脏分割。
  • DOI:
    10.3390/s21237942
  • 发表时间:
    2021-11-28
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Asaturyan H;Villarini B;Sarao K;Chow JS;Afacan O;Kurugol S
  • 通讯作者:
    Kurugol S
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sila Kurugol其他文献

Sila Kurugol的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sila Kurugol', 18)}}的其他基金

Robust quantitative MR imaging markers of response to therapy in Crohn’s Disease
克罗恩病治疗反应的稳健定量 MR 成像标记
  • 批准号:
    10536634
  • 财政年份:
    2021
  • 资助金额:
    $ 26.55万
  • 项目类别:
Robust quantitative MR imaging markers of response to therapy in Crohn’s Disease
克罗恩病治疗反应的稳健定量 MR 成像标记
  • 批准号:
    10371208
  • 财政年份:
    2021
  • 资助金额:
    $ 26.55万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 26.55万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 26.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 26.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 26.55万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 26.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 26.55万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 26.55万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 26.55万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 26.55万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 26.55万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了